id: pfos_serum_concentration_to_er_positive_breast_cancer
name: Serum Perfluorooctane Sulfonate (PFOS) Concentration â†’ Estrogen Receptor Positive
  (ER+) Breast Cancer
from_node:
  node_id: pfos_serum_concentration
  node_name: Serum Perfluorooctane Sulfonate (PFOS) Concentration
to_node:
  node_id: er_positive_breast_cancer
  node_name: Estrogen Receptor Positive (ER+) Breast Cancer
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: PFOS disrupts estrogen signaling pathways through endocrine disruption'
- 'Step 2: Environmental exposure occurs through contaminated drinking water, food
  chain bioaccumulation, and consumer products'
- 'Step 3: Chronic low-dose exposure alters estrogen receptor expression and activity
  in breast tissue'
- 'Step 4: Modified estrogen signaling promotes proliferation of ER+ tumor cells'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'V. Chang et al. 2023. "Serum perfluorooctane sulfonate and perfluorooctanoate
    and risk of postmenopausal breast cancer according to hormone receptor status:
    An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial."
    *International Journal of Cancer*. https://doi.org/10.1002/ijc.34487'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.489704'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: exposure_quartile
  direction: strengthens
  strength: moderate
  description: Third quartile PFOS showed statistically significant association (OR=1.59,
    95% CI 1.01-2.50) with ER+ tumors
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/pfos_serum_concentration_to_er_positive_breast_cancer.yaml
_category: biological
